Martin Weltman
Martin Weltman
Associate Professor of Medicine, Sydney Medical School
Verified email at
Cited by
Cited by
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ...
Nature genetics 41 (10), 1100, 2009
NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome
S Chitturi, S Abeygunasekera, GC Farrell, J Holmes‐Walker, JM Hui, ...
Hepatology 35 (2), 373-379, 2002
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
MD Weltman, GC Farrell, P Hall, M Ingelman‐Sundberg, C Liddle
Hepatology 27 (1), 128-133, 1998
Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
MD Weltman, GC Farrell, C Liddle
Gastroenterology 111 (6), 1645-1653, 1996
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction
MM Richardson, JR Jonsson, EE Powell, EM Brunt, ...
Gastroenterology 133 (1), 80-90, 2007
The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study
NA Koloski, M Jones, J Kalantar, M Weltman, J Zaguirre, NJ Talley
Gut 61 (9), 1284-1290, 2012
HFE mutations, hepatic iron, and fibrosis: ethnic‐specific association of NASH with C282Y but not with fibrotic severity
S Chitturi, M Weltman, GC Farrell, D McDonald, C Liddle, ...
Hepatology 36 (1), 142-149, 2002
Which patients with hepatitis C develop liver complications?
MH Khan, GC Farrell, K Byth, R Lin, M Weltman, J George, ...
Hepatology 31 (2), 513-520, 2000
Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment
MD Weltman, A Brotodihardjo, EB Crewe, GC Farrell, M Bililus, ...
Journal of viral hepatitis 2 (1), 39-45, 1995
Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi‐centre, randomized, double‐blind, placebo‐controlled trial
KC Morley, M Teesson, SC Reid, C Sannibale, C Thomson, N Phung, ...
Addiction 101 (10), 1451-1462, 2006
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance
KL Milner, D van der Poorten, M Trenell, AB Jenkins, A Xu, G Smythe, ...
Gastroenterology 138 (3), 932-941. e3, 2010
Modelling the hepatitis C virus epidemic in Australia
K Razali, HH Thein, J Bell, M Cooper-Stanbury, K Dolan, G Dore, ...
Drug and alcohol dependence 91 (2-3), 228-235, 2007
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
Influence of aging on oral-pharyngeal bolus transit and clearance during swallowing: scintigraphic study
IJ Cook, MD Weltman, K Wallace, DW Shaw, E McKay, RC Smart, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 266 (6 …, 1994
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
M Eslam, AM Hashem, R Leung, M Romero-Gomez, T Berg, GJ Dore, ...
Nature communications 6 (1), 1-10, 2015
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study
V Suppiah, S Gaudieri, NJ Armstrong, KS O'Connor, T Berg, M Weltman, ...
PLoS Med 8 (9), e1001092, 2011
Duodenal eosinophilia and early satiety in functional dyspepsia: Confirmation of a positive association in an A ustralian cohort
MM Walker, KR Aggarwal, LSE Shim, M Bassan, JS Kalantar, ...
Journal of gastroenterology and hepatology 29 (3), 474-479, 2014
An association between non‐alcoholic fatty liver disease and polycystic ovarian syndrome
MM Brzozowska, G Ostapowicz, MD Weltman
Journal of gastroenterology and hepatology 24 (2), 243-247, 2009
Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study
SA Coverdale, MH Khan, K Byth, R Lin, M Weltman, J George, ...
American Journal of Gastroenterology 99 (4), 636-644, 2004
The system can't perform the operation now. Try again later.
Articles 1–20